Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Pain Management Market, By Product
7.1. Veterinary Pain Management Market, By Product, 2020-2028
7.1.1. NSAIDs
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Anesthetics
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Opioids
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Others
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Veterinary Pain Management Market, By Indication
8.1. Veterinary Pain Management Market, By Indication, 2020-2028
8.1.1. Osteoarthritis
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Post-operative pain
8.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Veterinary Pain Management Market, By End User
9.1. Veterinary Pain Management Market, by End User, 2020-2028
9.1.1. Hospitals & Clinics
9.1.1.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Veterinary Pain Management Market, By Animal Type
10.1. Veterinary Pain Management Market, By Animal Type, 2020-2028
10.1.1. Livestock animal
10.1.1.1. Market Revenue and Forecast (2016-2028)
10.1.2. Companion Animal
10.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 11. Global Veterinary Pain Management Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Product (2016-2028)
11.1.2. Market Revenue and Forecast, By Indication (2016-2028)
11.1.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.1.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.1.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Product (2016-2028)
11.1.6.2. Market Revenue and Forecast, By Indication (2016-2028)
11.1.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.6.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Product (2016-2028)
11.2.2. Market Revenue and Forecast, By Indication (2016-2028)
11.2.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.2.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.2.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
11.2.6.2. Market Revenue and Forecast, By Indication (2016-2028)
11.2.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.6.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Product (2016-2028)
11.2.7.2. Market Revenue and Forecast, By Indication (2016-2028)
11.2.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.7.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Product (2016-2028)
11.2.8.2. Market Revenue and Forecast, By Indication (2016-2028)
11.2.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.8.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Product (2016-2028)
11.3.2. Market Revenue and Forecast, By Indication (2016-2028)
11.3.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.3.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.3.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
11.3.6.2. Market Revenue and Forecast, By Indication (2016-2028)
11.3.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.6.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Product (2016-2028)
11.3.7.2. Market Revenue and Forecast, By Indication (2016-2028)
11.3.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.7.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Product (2016-2028)
11.3.8.2. Market Revenue and Forecast, By Indication (2016-2028)
11.3.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.8.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Product (2016-2028)
11.4.2. Market Revenue and Forecast, By Indication (2016-2028)
11.4.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.4.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.4.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
11.4.6.2. Market Revenue and Forecast, By Indication (2016-2028)
11.4.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.6.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Product (2016-2028)
11.4.7.2. Market Revenue and Forecast, By Indication (2016-2028)
11.4.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.7.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Product (2016-2028)
11.4.8.2. Market Revenue and Forecast, By Indication (2016-2028)
11.4.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.8.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Product (2016-2028)
11.5.5.2. Market Revenue and Forecast, By Indication (2016-2028)
11.5.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.5.4. Market Revenue and Forecast, By Animal Type (2016-2028)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Product (2016-2028)
11.5.6.2. Market Revenue and Forecast, By Indication (2016-2028)
11.5.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.6.4. Market Revenue and Forecast, By Animal Type (2016-2028)
Chapter 12. Company Profiles
12.1. Boehringer Ingelheim GmbH
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bayer AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Zoetis
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Merck and others
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Elanco
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Aratana Therapeutics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Company 7
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Norbrook among others
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms